Satellos Bioscience

Satellos Bioscience is a company listed under the stock ticker MSCLF (US).

View the org chart displaying its 14 main executives

Most searched biographies at Satellos Bioscience

• Frank Gleeson, Chief Executive Officer and Director
• William Mcvicar, Director
• Rima Al-Awar, Director

Popular executive movements at Satellos Bioscience

• Alan Jacob, Chief Medical Officer, has left the company  (posted on January 24 2024).

Create your alert
to follow the executive moves at Satellos Bioscience.

Satellos Bioscience has 2,288 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on May 13 2024).
• Aardvark Therapeutics has just announced a $85 Million fundraising (posted on May 12 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Vik Bajaj - Director at Interline Therapeutics

Learn more about the Biotechnology industry >

Press releases by Satellos Bioscience

Social media about Satellos Bioscience

• Satellos Bioscience on Wikipedia, Google News & Yahoo Finance
• Satellos Bioscience on LinkedIn, Twitter & YouTube

Contact by email its executives including Rima Al-Awar

Call Satellos Bioscience at +1 858...

View the org chart

Register to receive your alert

Report an error